Evidence map›Paper›PMID 27287441›Full record

ArticleBMC infectious diseases2016

Neonatal infections with multidrug-resistant ESBL-producing E. cloacae and K. pneumoniae in Neonatal Units of two different Hospitals in Antananarivo, Madagascar.

T Naas, G Cuzon, A L Robinson, Z Andrianirina, P Imbert, E Ratsima, Z N Ranosiarisoa, P Nordmann, J Raymond

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Observational
  7. Observational
  8. Article
  9. Review
  10. Article
  11. Article
  12. TheInternational journal of genomics · 2018
    Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

T NaasBacteriologie, APHP, EA7361 Univ Paris Sud, Le Kremlin-Bicetre, France. thierry.naas@bct.aphp.fr.
G CuzonBacteriologie, APHP, EA7361 Univ Paris Sud, Le Kremlin-Bicetre, France.
A L RobinsonService de Pédiatrie, Hôpital Tsaralanana, Antananarivo, Madagascar.
Z AndrianirinaService de Néonatologie, Hôpital Soavinandriana, Antananarivo, Madasgascar.
P ImbertHôpital Begin, Vincennes, France.
E RatsimaInstitut Pasteur, Antananarivo, Madagascar.
Z N RanosiarisoaService de Néonatologie, Hôpital Befelatanana, Antananarivo, Madagascar.
P NordmannMedical Microbiology, Fribourg Univ, Fribourg, Switzerland.
J RaymondUniversity Paris Descartes Bacteriologie, Hôpital Cochin, Paris, France. josette.raymond@cch.aphp.fr.
Assistance Publique – Hôpitaux de Paris · FRHôpital Cochin · FRHôpital d'Instruction des Armées Bégin · FRInstitut Pasteur de Madagascar · MGUniversity of Fribourg · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe investigated the molecular mechanism of ß-lactam resistance in extended-spectrum ß-lactamase (ESBL)-producing Enterobacterial strains isolated in neonatal units of different hospitals in Anatnanarivo, Madagascar.

methodsBacteria were identified by standard biochemical methods, disc diffusion antibiograms and Etest. Resistance genes were sought by PCR. Strains were characterized by Rep-PCR (Diversilab), plasmid analysis and rep-typing.

resultsFrom April 2012 to March 2013, 29 ESBL-producing E. cloacae and 15 K. pneumoniae were isolated from blood culture (n = 32) or gastric samples (n = 12) performed at day 0 or 2 from 39/303 newborns suspected of early neonatal infection. These infants were treated with expanded spectrum cephalosporins, due to lack of carbapenems, leading to a high mortality rate (45 %). Isolates recovered were all, but 4, multidrug resistant, particularly to fluoroquinolones (FQ) except for 21 E. cloacae isolates. Isolates produced TEM-1 and CTX-M-15 ß-lactamases and their genes were located on several self-transferable plasmids of variable sizes sizes that could not be linked to a major plasmid incompatibility group. E. cloacae isolates belonged to 6 Rep-types among which two counted for 11 isolates each. The FQ resistant E. cloacae isolates belonged to one clone, whereas the FQ susceptible E. cloacae isolates belonged to four clones. The K. pneumoniae isolates belonged to 9 Rep-types among which one included five isolates.

conclusionThis study is the first molecular characterization of ESBL-producing isolates from neonatology units in Madagascar, a country with limited epidemiological data. It revealed an important multi-clonal dissemination of CTX-M-15-producing isolates reflecting both the high community carriage and the very early nosocomial contamination of the neonates.

Indexed as

Anti-Bacterial Agentsbeta-LactamasesCross InfectionDNA, BacterialDrug Resistance, Multiple, BacterialElectrophoresis, Gel, Pulsed-FieldEnterobacterEnterobacter cloacaeEnterobacteriaceae InfectionsFemaleHumansInfant, Extremely PrematureInfant, NewbornInfant, Newborn, DiseasesInfant, PostmatureInfant, PrematureAnti-Bacterial Agentsbeta-lactamase CTX-M-15beta-Lactamasesbeta-lactamase TEM-1DNA, BacterialESBLMadagascarNeonatologyOutbreak

Identifiers

PMID27287441
PMCPMC4902894
OpenAlexW2410766664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.